Clinical trial
An Open Label, Randomized Controlled Study to Compare Healing of Severe Diabetic Foot Ulcers and Forefoot Amputations in Diabetics With and Without Moderate Peripheral Arterial Disease Treated With Kerecis Omega3 Wound and SOC vs. SOC Alone
NCT04257370 is registered in ClinicalTrials.gov with Kerecis Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Randomized Controlled Study to Compare Healing of Severe Diabetic Foot Ulcers and Forefoot Amputations in Diabetics With and Without Moderate Peripheral Arterial Disease Treated With Kerecis Omega3 Wound and SOC vs. SOC Alone
- Lead sponsor
- Kerecis Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 9, 2020
- Completion date
- November 25, 2022
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amputation, dehiscence of amputation stump, diabetic foot ulcer